Very late stent thrombosis in patients with first-generation drug-eluting stents: A systematic review of reported cases

Abstract

Age, mean ± SD, years 59.1 ± 12.2 Not reported, n (%) 19 (11.1) Sex, n (%) Female 22 (12.8) Not reported 20 (11.6) DES type, n (%) PES 70 (40.7) SES 102 (59.3) Occluded artery, n (%) LAD 97 (56.4) RCA 35 (20.4) LCx 12 (7.0) LM 2 (1.2) Multiple arteries 6 (3.5) Not reported 20 (11.6) Clinical presentation, n (%) MI 106 (61.6) Angina 7 (4.1) Unstable angina 28 (16.3) Sudden death 1 (0.6) Other 6 (3.5) Not reported 24 (13.9) In-hospital mortality, n (%) 17 (9.9) Not reported 29 (16.9) Time from index PCI to VLST, days Mean ± SD 849.4 ± 411.8 Median (IQR) 752 (517, 1020) Time from ASA discontinuation to VLST, days Mean ± SD 112.6 ± 300 Median (IQR) 8.5 (7, 33) Time from thienopyridine discontinuation to VLST, days Mean ± SD 405.9 ± 434.2 Median (IQR) 304 (30, 609)